AzTrials
AzTrials

Protein MetabolismNCT03142737

Are the "ounce-equivalents" in the Protein Foods Groups Really Equivalent?

A study testing Red kidney bean intake, Eggs intake and Peanut butter intake in people with Protein Metabolism, run by University of Arkansas at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants. Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Protein Metabolism
What is being tested?
Red kidney bean intake, Eggs intake and Peanut butter intake
Could I receive a placebo?
No, everyone receives an active treatment
How many people
45 participants
Where
1 siteUnited States
Study dates
8 May 2017to 15 May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Men and women, ages 20-40 years
  • BMI from 20 to 29.9 kg/m2

Who cannot join

  • Current diagnosis of diabetes
  • History of malignancy in the 6 months prior to enrollment
  • History of gastrointestinal bypass surgery
  • History of a chronic inflammatory condition or other chronic diseases (Lupus, HIV/AIDS, etc)
  • Female subjects who are currently pregnant
  • Subjects who are unable to eat animal protein
Show all 12Show fewer
  • Subjects who are unable to stop eating protein or Amino Acid (AA) supplements during the participation
  • Subjects who report regular resistance training (more than twice per week)
  • Subjects who have concomitant use of corticosteroids (ingestion, injection or transdermal)
  • Hemoglobin less than 9.5 g/dL at the screening visit
  • Platelets less than 250,000 at the screening visit.
  • Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas, 72202

Other trials in United States

About this study

The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.

Read the detailed description

Over the past 35 years the United States Department of Agriculture (USDA) Dietary Guidelines for Americans (DGAs) has sought to translate recommendations on nutrient requirements (i.e., Recommended Dietary Allowances (RDAs) from the Food and Nutrition Board of the Institute of Medicine (IOM) into practical nutritional advice for the American public. Over the same time interval in which the Dietary Guidelines have existed the occurrence of nutrition-related health problems in the United States has escalated dramatically, showing that the population of obesity in U.S. has reached to a total of 35.8%. In addition, the lack of appropriate focus on protein nutrition is a major shortcoming of the DGAs. Not only is the amount of protein not a major focus, but also absolutely no mention is made of protein quality. Protein quality refers to the amount, profile, and true ileal digestibility of the essential amino acids (EAAs) in the protein. However, the concept of protein quality is not new, as the Protein Digestible Corrected Amino Acid Score was published by the Food and Agriculture Organization of the World Health Organization in 1993. Although animal protein (and beef specifically) has much higher the Digestible Indispensable Amino Acid Score (DIAAS) than plant proteins, often by as much as two fold, DIAAS has not taken account of the importance of the amount and profile of EAAs in individuals proteins. Moreover, the misrepresentation of the equivalencies of various food sources of protein in MyPlate raises the question of the process by which this occurred, and how can the process be influenced to more accurately reflect that high quality of animal proteins, including beef? Therefore, we propose to make these measurements in response to intake of "equivalent "(according to MyPlate) amounts of beef, kidney beans, eggs and peanut butter. Demonstration that the functional responses to these varied sources of protein coincide with the predictions from the USDA nutrient data base and calculation of the DIAAS will provide needed support to redefine "ounce equivalents" of protein food sources according to those data bases for all animal and plant sources of protein.

Being tested
Red kidney bean intake, Eggs intake, Peanut butter intake, Ground beef intake, Intact beef intake

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Red kidney bean intakeOther

    Each participant will consume 1/2 cup of cooked red kidney bean

  • Eggs intakeOther

    Each participant will consume 2 cooked large eggs.

  • Peanut butter intakeOther

    Each participant will consume 2 tablespoons of peanut butter.

  • Ground beef intakeOther

    Each participant will consume 2 ounces of 90% lean ground beef.

  • Intact beef intakeOther

    Each participant will consume 2 ounces of intact beef.

Study groups in NCT03142737
Study groupRoleWhat they receive
Red kidney bean intakeExperimentalSubjects will consume 1/2 cup of cooked red kidney bean following diet normalization for 3 days.
Receives: Other: Red kidney bean intake
Eggs intakeExperimentalSubjects will consume 2 cooked large eggs following diet normalization for 3 days.
Receives: Other: Eggs intake
Peanut butter intakeExperimentalSubjects will consume 2 tablespoons of peanut butter following diet normalization for 3 days.
Receives: Other: Peanut butter intake
Ground beef intakeExperimentalSubjects will consume 2 ounces of 90% lean ground beef following diet normalization for 3 days.
Receives: Other: Ground beef intake
Intact beef intakeExperimentalSubjects will consume 2 ounces of intact beef following diet normalization for 3 days.
Receives: Other: Intact beef intake

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Net protein synthesis rate

    Net protein synthesis rate is determined in the 4.5-hour basal fasted period and 4-hous post-meal period over the 8.5-hour experimental period

    Measured: Up to 8.5 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 May 2017
  2. Study start8 May 2017
  3. Primary completion6 Mar 2018
  4. Study completion15 May 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
45 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03142737
Sponsor's protocol ID
205366
Status last verified
Jun 2019
First submitted
2 May 2017
Last updated
3 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Red kidney bean intake, Eggs intake and Peanut butter intake in people with Protein Metabolism, run by University of Arkansas at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Net protein synthesis rate (time frame: Up to 8.5 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in